Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency may be one of the risk factor for type 2 diabetes mellitus. Objective: To observe erythrocyte G6PD status in type 2 female diabetic patients and also to find out its relationship with glycosylated hemoglobin. Methods: This cross sectional study was carried out in the
iabetes mellitus is a multifactorial disease resulting from interaction of both genetic and environmental It has been stated that oxidative stress and impaired release of nitric oxide may be the contributory factors in the pathogenesis of diabetes 3 . Recently, researchers found that G6PD deficient individuals may suffer from an episode of raised H 2 O 2 , which acts as an oxidant and thereby may lead to development of type 2 factors 1 . Both the insulin resistance and decreased insulin secretion are the major features of the pathophysiology of type 2 diabetes and typically affects individuals older than 40 years 2 .
D
Article diabetes mellitus 4 . According to Beutler et al., G-6-PD deficiency is one of the common enzymopathy in human being affecting about 400 million people worldwide [5] [6] [7] . It is suggested that there may be a positive association of G6PD deficiency with diabetes mellitus. 8 9 .The link between diabetes mellitus and G6PD deficiency has been currently focused in many studies [5] [6] [7] [8] [9] It has been reported that glucose tolerance is altered in subjects with G6PD deficiency characterized by accumulation of glucose in alternative pathway, which increases the advanced glycosylated end product 3, 10 . Prolonged hyperglycemia may increase the work load on G6PD enzyme to convert glucose-6-phosphate to 6-phosphogluconate followed by its excessive metabolic disintegration and thereby results in reduced G6PD activity or G6PD deficiency 11 . Recently, it has been reported that oxidative stress leads to development of late complications of diabetes and also participates in beta cell dysfunction or insulin resistance 12 . In a state of oxidative stress, most of the glutathione is consumed. Enzymes and other proteins are subsequently damaged by oxidants 9 . Therefore lower blood G6PD activity and lower intake of antioxidants are found to be risk factor for occurrence of the disease 13 . Various investigators reported that G6PD deficient individuals have lower antioxidant stores which makes them vulnerable to oxidative stress. So, lower intake of antioxidant specially in G6PD deficient state, carries higher risk for diabetes mellitus 14 . In our country, diabetes related complications are the usual findings in diabetic patients. Associated deficiency of enzyme G6PD may enhance these complications. Although G6PD deficiency is not uncommon in our country but there is scarcity of data on this regards especially on diabetes. A good number of studies in other countries [5] [6] [7] 11, 13 have demonstrated high prevalence of G6PD deficiency in diabetic patients but no such published data is available in Bangladesh. Therefore, this study was undertaken to observe the erythrocyte G6PD status in female patients with type 2 diabetes mellitus in order to explore the role of this enzyme deficiency as one of the risk factor for diabetes mellitus & also to observe its relationship with HbA1c level. Moreover, the finding of this study may also be helpful to the clinicians for better management of the complications of diabetes mellitus.
Methods
The present cross sectional study was carried out in the Department of Physiology, BSMMU, Dhaka between January 2009 to December 2009 and the protocol was approved by the ethical committee of the Department of Physiology. Total number of 90 female subjects of 40 to 60 years of age were included in this study. 60 patients with type 2 diabetes were taken as the study groups (group B). Thirty (30) age and sex matched apparently healthy non-diabetic subjects were considered as control (group A). On the basis of blood HbA 1 C level, study group was further subdivided into two subgroups. 30 patients with HbA 1 C (4.8-6%) were designated as controlled diabetics and constituted group B 1 and 30 patients with HbA 1 C (> 6%) were termed as uncontrolled diabetes and were included in group B 2 . Patients with presence of hypertension (diastolic B.P> 90 mmHg and systolic B.P>140 mmHg), cataract and history of any heart diseases were excluded from the study. All the study subjects (group B) were selected from Out Patient Department of Bangladesh Institute Of Health Sciences Hospital (BISH) ,Dhaka and control (group A) were selected by personal contact. After selection of the subjects, the purpose of the study was explained to each subject. When they agreed for participation, then an informed written consent was taken. Detailed family and medical history were taken. Thorough Physical examinations were done and all informations were recorded in a prefixed questionnaire.Then 5 ml of venous blood was collected from ante-cubital vein from each subject for estimation of hematological and biochemical tests.
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G6PD in Type 2 Diabetes
Blood G6PD enzyme activity was determined by Spectrophotometric method and Glycosylated Hemoglobin was estimated by Flex reagent cartridge method. HbA 1 
Results
In this study, all the groups were matched for age but the mean BMI were significantly higher in group B 1 and B 2 (p<0.01) in comparison to that of group A. But this value was almost similar in group B 1 and B 2 . (Table I ). Data expressed as mean ± SD Group A = Apparently healthy non diabetic subjects (Control group). Group B = Type 2 diabetic female patients (Study group). Group B 1 = Controlled Group B 2 = Uncontrolled ** = p<0.01 ns= Non significant ***= p<0.001 n = Number of subjects.
The mean erythrocyte G6PD levels were significantly (p<0.001) lower in both the study groups B 1 and B 2 in comparison to that of control group A. On the other hand, though this value was lower in group B 2 in comparison to that of group B 1 but the difference was statistically not significant. (Figure 1) Data are expressed as Mean ± SD. Group A = Apparently healthy non diabetic subjects (Control group). Group B = Type 2 diabetic female patients (Study group). Group B 1 = Controlled Group B 2 = Uncontrolled ** = p<0.01 ***= p£0.001 .
Figure 1:
Erythrocyte G6PD level in different groups of subjects (n =90).
In this study, 6 (20%) of the controlled diabetics and 2 (6%) of uncontrolled diabetic subjects were G6PD deficient and they had G6PD level below <245 mU/10 9 RBC and <200 mU/10 9 RBC respectively. Though the percentage of G6PD deficiency was higher in B 1 than that of B 2 but the difference was statistically non significant. (Figure 2 & Table II ) The relationship of G6PD with HbA 1 c showed negative correlatation with HbA 1 C in the diabetic groups which was statistically significant for group B 2 (r = -0.425; p < 0.05) but not for group B 1 (r = -0.331 p < 0.05). (Figure 3 )
Discussion
In the present study, mean erythrocyte G6PD level in the healthy subjects was within normal range and almost similar to those observed by the investigators from different countries. 13, 15 Significantly lower mean erythrocyte G6PD level in both the groups of diabetics compared to non diabetics in this study is comparable to the findings reported by other researchers. 13, 15, 16 .
In the present study, no G6PD deficiency was found in non diabetic healthy control which is consistent to some other investigators 13 but two studies found 10% and 2% enzyme deficiency in non diabetics 12, 15 .
On the other hand, in 26% deficiency of enzyme of diabetic patients is similar to those reported by some investigators 12, 13, 15 where they found 14%, 7% and 3% G6PD enzyme deficient diabetic females in Iraq, Saudi-Arabia and Taiwan respectively. In this study, the percentage of G6PD deficiency was higher in controlled than that of uncontrolled diabetes. Similar observation was also made by Niazi 15 . Furthermore, the results of the study showed a positive association between G6PD deficiency and diabetes which is also similar to the findings observed by some other investigators 12, 13, 15 .
Again, in the present study HbA 1 C showed significant negative correlation with Erythrocyte G6PD level in uncontrolled diabetes.
It has been suggested that various factors attributed to the association of the G6PD deficiency with diabetes mellitus. It has been suggested that G6PD deficient individuals are highly susceptible to oxidative stress, which is one of the risk factor for diabetes, and thereby lower activity of this enzyme may be a causative factor for diabetes. It may be related to DM related gene transmitted from the ancestor of G6PD deficient subjects. Genetic deficiency of G6PD is probably the result of rather than a predisposing cause of diabetes mellitus 12 . In this study, higher incidence of G6PD deficiency observed in controlled diabetes in comparison to that of uncontrolled diabetes may be link to the fact that this deficiency is possibly masked in uncontrolled diabetes 15 .
Oxidative stress causes alteration of membrane fluidity, decrease availability of NO and increased intracellular calcium content thereby may lead impairment of insulin action 12 .
In addition, increase in advanced glucosylating end products may be related to excess buildup of glucose in the polyol pathway due to deficiency of G6PD 16 .
In the present study, a few percentage of diabetic female showed deficiency of G6PD which is in favor of the suggestion that this enzyme deficiency may be a risk factor for the occurrence of the disease. Again, higher percentage of G6PD deficiency in controlled diabetes in comparison to that of uncontrolled diabetes of the present series indicates the higher incidence of the enzyme deficiency in this group of diabetic patients. On the other hand, markedly lower value of this enzyme in deficient patients of uncontrolled diabetes is in favor of the suggestion that enzyme level is markedly lower in uncontrolled diabetes.
Conclusion
This study reveals that, G6PD deficiency may be a risk factor for type 2 diabetes mellitus which may be linked to increased oxidative stress in deficient subjects. Therefore, routine screening of G6PD enzyme in type 2 diabetes patients is necessary to provide appropriate medical care such as supplementation of antioxidant and thereby may be helpful to minimize diabetes related other complications.
